Apogee Therapeutics, Inc.

General ticker "APGE" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $3.9B (TTM average)

Apogee Therapeutics, Inc. follows the US Stock Market performance with the rate: 52.9%.

Estimated limits based on current volatility of 2.9%: low 84.58$, high 89.65$

Factors to consider:

  • Total employees count: 261 (+33.2%) as of 2025
  • Company does not operate outside US (retrieved using AI)
  • Price in estimated range
  • Earnings for 3 months up through Q1 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [44.31$, 102.17$]
  • 2026-12-31 to 2027-12-31 estimated range: [28.76$, 71.29$]

Financial Metrics affecting the APGE estimates:

  • Negative: with PPE of -18.2 at the end of fiscal year the price was very high
  • Negative: negative Operating cash flow
  • Negative: negative Operating income
  • Negative: negative Net income
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Negative: negative Industry operating cash flow (median)
  • Positive: -4.41 < Investing cash flow per share per price, % of -3.84
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term APGE quotes

Long-term APGE plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $93.00MM $216.87MM $285.60MM
Operating Income $-93.00MM $-216.87MM $-285.60MM
Non-Operating Income $9.02MM $34.74MM $30.03MM
R&D Expense $68.42MM $167.87MM $214.71MM
Income(Loss) $-83.98MM $-182.13MM $-255.56MM
Taxes $0.00MM $0.02MM $0.28MM
Net Income(Loss)* $-83.98MM $-182.15MM $-255.84MM
Stockholders Equity $379.91MM $716.79MM $903.88MM
Assets $401.40MM $753.95MM $937.13MM
Operating Cash Flow $-74.76MM $-171.17MM $-227.45MM
Capital expenditure $0.17MM $1.15MM $5.15MM
Investing Cash Flow $-273.91MM $-300.46MM $-179.57MM
Financing Cash Flow $315.39MM $495.11MM $396.49MM
Earnings Per Share** $-1.66 $-3.30 $-4.22

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.